News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Globus Medical, Inc. (GMED) Reveals FDA Warning Letter Over MicroFuse Putty



10/15/2013 10:17:04 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Globus Medical says the FDA issued a warning letter over its MicroFuse bone-growth putty. Globus Medical (NYSE:GMED) said the FDA issued a warning letter last month over its MicroFuse bone-growth putty, sending share prices down today on Wall Street. Audubon, Pa.-based Globus said the Sept. 26 warning letter flagged "deficiencies" in its response to a Form 483 warning the watchdog agency issued after inspecting the medical device company's Audubon facility in May and June.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES